Bronchoscopy in ventilator-associated pneumonia: agreement of calibrated loop and serial dilution

American Journal of Respiratory and Critical Care Medicine
Bekele AfessaSteve G Peters

Abstract

Although the serial dilution technique for quantitative culture of bronchoalveolar fluid is considered to be the gold standard for the diagnosis of ventilator-associated pneumonia, it is more labor intensive than the calibrated loop technique. We sought to determine the agreement between the calibrated loop and serial dilution techniques in the diagnosis of ventilator-associated pneumonia. We prospectively measured bacterial colony counts by the serial dilution and calibrated loop techniques in 121 bronchoalveolar lavage samples of 104 patients with suspected ventilator-associated pneumonia. At the time of bronchoscopy, patients had received mechanical ventilation for a median of 8 d. Patients were receiving antibiotics when 90 of the 121 (74.4%) bronchoalveolar samples were obtained. The colony counts of 13 bacterial isolates were too numerous to count by the calibrated loop technique; by serial dilution technique, their counts ranged from 4.70 to 6.74 log10 cfu/ml. Fifty other bacteria had paired colony counts measured by each of the two techniques: the bias (95% confidence interval) between the two techniques was -0.380 (-0.665 to -0.095) log10 cfu/ml, with precision of 1.002 log10 cfu/ml and 95% limits of agreement of -2.34...Continue Reading

References

Apr 20, 2001·Intensive Care Medicine·M LlewelynUNKNOWN International Sepsis Forum
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Jean Chastre, Jean-Yves Fagon
Feb 14, 2003·Intensive Care Medicine·R D HubmayrUNKNOWN Société de Réanimation de Langue Française
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America

❮ Previous
Next ❯

Citations

Apr 7, 2007·Current Opinion in Pulmonary Medicine·Graciela J Soto
Mar 27, 2007·American Journal of Respiratory and Critical Care Medicine·Eric B MilbrandtDerek C Angus
Jun 2, 2006·American Journal of Respiratory and Critical Care Medicine·Marin H Kollef
May 16, 2020·American Journal of Respiratory and Critical Care Medicine·Alfons TorregoJordi Mancebo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
P PóvoaH Sabino
The New England Journal of Medicine
Sébastien GibotPierre-Edouard Bollaert
American Journal of Respiratory and Critical Care Medicine
Jean ChastreC Gibert
© 2021 Meta ULC. All rights reserved